A recent episode of the Difficult Conversation Africa Podcast has shed light on the persistent discrimination faced ...

Stoke Therapeutics advances TANGO ASO for Dravet, with Zorevunersen Phase 3 data showing seizure reduction and a delayed 2027 ...

NASA's SpaceX Crew-11 mission is ending early to bring back a member with a medical issue. Astronauts who spend a long time ...

Full-year 2025 preliminary1 U.S. net product revenues of $689 millionSYFOVRE® (pegcetacoplan injection) total injection demand grew 17% ...

The National Commission for Persons with Disabilities, under the Federal Ministry of Humanitarian Affairs, has summoned the ...

Regardless of whether it is a swept-source or spectral-domain platform, OCT angiography is comparably useful for monitoring ...

January is Glaucoma Awareness Month, prompting Rutgers Health experts to underscore the importance of early detection and ...

As Glaucoma Awareness Month highlights evolving practice, specialists describe how artificial intelligence, sustained drug ...

Until now, it has been difficult to maintain retinal ganglion cells deep inside organoids over extended periods. The supply ...

Weight-loss injections - miracle solution for the millions unable to tackle excess weight by conventional means? Or sticking ...

Ocugen has announced positive preliminary 12-month data from its phase 2 ArMaDa trial evaluating OCU410 (AAV5-RORA) for the ...